Silo Pharma (SILO) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to 0.78.
- Silo Pharma's Equity Ratio fell 90.84% to 0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78, marking a year-over-year decrease of 90.84%. This contributed to the annual value of 0.68 for FY2024, which is 1482.21% down from last year.
- Latest data reveals that Silo Pharma reported Equity Ratio of 0.78 as of Q3 2025, which was down 90.84% from 0.74 recorded in Q2 2025.
- Over the past 5 years, Silo Pharma's Equity Ratio peaked at 0.91 during Q3 2022, and registered a low of 0.68 during Q4 2024.
- Its 5-year average for Equity Ratio is 0.8, with a median of 0.8 in 2023.
- Per our database at Business Quant, Silo Pharma's Equity Ratio soared by 21867.93% in 2021 and then crashed by 1482.21% in 2024.
- Over the past 5 years, Silo Pharma's Equity Ratio (Quarter) stood at 0.86 in 2021, then grew by 2.81% to 0.89 in 2022, then dropped by 10.22% to 0.8 in 2023, then dropped by 14.82% to 0.68 in 2024, then increased by 15.5% to 0.78 in 2025.
- Its last three reported values are 0.78 in Q3 2025, 0.74 for Q2 2025, and 0.68 during Q1 2025.